Stay updated on Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial

Sign up to get notified when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page shows an added Revision: v3.5.0 and a removed Revision: v3.4.3. This appears to be an administrative versioning update rather than a modification to the study data or content.
    Difference
    0.1%
    Check dated 2026-03-19T06:38:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site revision was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:18:21.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Primary outcome maintenance phase wording updated to 'Baseline through Week 48' from 'post-randomization through Week 48'.
    Difference
    0.3%
    Check dated 2026-02-18T16:47:45.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The change is a minor revision update from v3.4.1 to v3.4.2; no substantive content changes are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:31:21.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    A new revision label v3.4.1 was added and the previous revision v3.4.0 was removed. This appears to be a cosmetic/versioning update that does not change study content or user-facing information on the page.
    Difference
    0.1%
    Check dated 2026-02-04T10:42:14.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Added a Show glossary option and minor editorial updates to labeling and revision/version text (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:31:30.000Z thumbnail image

Stay in the know with updates to Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.